Jun Suk Kim

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Ann‐Lii Cheng, Yoon‐Koo Kang, Zhendong Chen et al. · The Lancet Oncology · 2008 · 5.8K citations

Medicine, Oncology, Pharmacotherapy +11

Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study

Se Hoon Park, Heung-Moon Chang, Jun Suk Kim et al. · The Lancet Oncology · 2011 · 483 citations

Medicine, Oncology, Pharmacology +9

Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia

Qing Lan, Chao A. Hsiung, Keitaro Matsuo et al. · Nature Genetics · 2012 · 354 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial

Ann‐Lii Cheng, Zhongzhen Guan, Zhendong Chen et al. · European Journal of Cancer · 2012 · 261 citations · Full text

Medicine, Oncology, Pharmacology +13

Two‐Terminal Multibit Optical Memory via van der Waals Heterostructure

Minh Dao Tran, Hyun Kim, Jun Suk Kim et al. · Advanced Materials · 2018 · 237 citations

Engineering, Electrical Engineering, Materials Science +17